You are here

Implantable Pacemaker Products Report, 2019 - Global Sales to Exceed $5.3 Billion by 2023

DUBLIN, Oct. 9, 2019 /PRNewswire/ -- The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering.

The global market for implantable pacemaker products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2017-2023).

Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 5.1% during the 2017-23 forecast, increasing from approximately $3,940.3m in 2017 to an estimated $5,324.2m in 2023.

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable pacemaker products market.

Implantable pacemaker products covered by this report include:

  • single-chamber pacemakers, including leadless pacemakers
  • dual-chamber pacemakers
  • biventricular pacemakers, also known as cardiac resynchronization therapy pacemakers (CRT-P)

Topics covered include:

  • An overview of implantable pacemaker products, including: single chamber, dual-chamber, and cardiac resynchronization therapy pacemakers (CRT-P, or biventricular pacemakers).
  • Selected statistics for cardiac rhythm disorders and heart failure for the major regions covered in this report (eg the US, five major EU markets, and Japan).
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by country/region.
  • Discussion of key drivers and limiters impacting the major product segments.
  • A review of emerging technologies which could impact sales of existing devices.

Report Highlights:

  • Total unit sales for implantable pacemaker products are steadily increasing due to a number of factors, including: the increasing prevalence of CVD and cardiac rhythm disorders, advances in CVD diagnostics, and demand for cardiac rhythm disorder therapies in emerging markets.
  • In 2017, dual-chamber pacemakers accounted for the majority of worldwide implantable pacemaker product sales. Dual-chamber pacemakers are projected to account for the majority of total product sales throughout the forecast period covered by this report (2017-23).
  • The global market for implantable pacemaker products is anticipated to increase at a CAGR of 5.1% during the forecast period, reaching approximately $5,324.2m in total product sales by 2023.
  • The US was the largest market based on total implantable pacemaker product sales in 2017. Sales of these products to the US accounted for approximately 35.6% of total product sales in 2017.
  • Implantable pacemaker insertion is the primary treatment for certain cardiac rhythm disorders, specifically bradyarrhythmia. lf left untreated, severe forms of bradyarrhythmia can cause cardiac arrest and death. While external pacemakers may also be used to treat bradyarrhythmia, they are not a convenient long-term solution.

Key Topics Covered

Executive Summary
Exhibit ES-1: Implantable pacemaker products, global market forecast, 2017-23
Exhibit ES-2: Global implantable pacemaker products market, share by country/region, 2017
Exhibit ES-3: Drivers and limiters of growth - implantable pacemaker products

Cardiac Rhythm Disorders Overview
Sick sinus syndrome
Bradycardia
Heart block
Tachycardia
Atrial fibrillation
Heart failure
Diagnosis and treatment
Bibliography
Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias, based on health care utilization, select countries
Exhibit 1-2: Estimated number of hospital discharges for conduction disorders and cardiac arrhythmias, select countries
Exhibit 1-3: Estimated prevalence of atrial fibrillation, select countries, 2018
Exhibit 1-4: Estimated prevalence of chronic heart failure, select countries, 2018
Exhibit 1-5: Estimated prevalence of acute decompensated heart failure, select countries, 2018. 1-10

Pacemaker Devices
Implantable pacemaker systems
Implantable pacemaker products
Developments in implantable pacemaker technology
Temporary pacing systems
External pacemaker products
Bibliography
Exhibit 2-1: NBG code for implantable pacemaker systems
Exhibit 2-2: Selected implantable pacemakers and manufacturers
Exhibit 2-3: EBR Systems' WiSE CRT system
Exhibit 2-4: Selected external pacemakers and manufacturers

Implantable Pacemaker Products Market
Global market insights
Market value
Technology trends
Market drivers and limiters
Implantable pacemaker products overview
Market leaders
Competitive strategies
Emerging competition
Global competitors
Market forecast
Market forecast: US
Market forecast: five major EU markets
Market forecast: Japan
Market forecast: rest of the world
Bibliography
Exhibit 3-1: Implantable pacemaker products, global market forecast ($m), 2017-23
Exhibit 3-2: Implantable pacemaker products, global market forecast ($m) by product type, 2017-23
Exhibit 3-3: Global implantable pacemaker product sales, share by product segment, 2017
Exhibit 3-4: Global implantable pacemaker products market, share by country/region, 2017
Exhibit 3-5: Global implantable pacemaker product sales, combined market forecast ($m), by country/region, 2017-23
Exhibit 3-6: Drivers and limiters of market growth - implantable pacemaker products
Exhibit 3-7: Implantable pacemaker products, share by product type, 2017 and 2023
Exhibit 3-8: Global implantable pacemaker products market, share by supplier, 2017
Exhibit 3-9: US Implantable pacemakers, procedure volumes forecast (000s), 2017-23
Exhibit 3-10: US Implantable pacemaker product sales, market forecast ($m) by product type, 2017-23
Exhibit 3-11: US implantable pacemaker products market, share by supplier, 2017
Exhibit 3-12: 5EU Implantable pacemakers, procedure volumes forecast (000s), 2017-23
Exhibit 3-13: 5EU Implantable pacemaker product sales, market forecast ($m) by product type, 2017-23
Exhibit 3-14: 5EU implantable pacemaker products market, share by supplier, 2017
Exhibit 3-15: Japanese Implantable pacemakers, procedure volumes forecast (000s), 2017-23
Exhibit 3-16: Japanese Implantable pacemaker product sales, market forecast ($m) by product type,
Exhibit 3-17: Japanese implantable pacemaker products market, share by supplier, 2017
Exhibit 3-18: RoW Implantable pacemaker product sales, market forecast ($m) by product type
Exhibit 3-19: RoW implantable pacemaker products market, share by supplier, 2017

Appendix: Company Listing

For more information about this report visit https://www.researchandmarkets.com/r/cwulrf

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/implantable-pacemaker-products-report-2019---global-sales-to-exceed-5-3-billion-by-2023--300934677.html

SOURCE Research and Markets